← Back to Blog

Chronic Pain Clinical Trials: How to Find and Join One

Abstract path across clinical trial platforms

A chronic pain clinical trial is a research study that tests a treatment in volunteers who have a specific condition, and most of them ask first for a clear diagnosis. You find open studies in public registries, confirm the location and status with the study team, pass a screening, and sign an informed consent form before anything starts. If you have widespread pain and fatigue but no objective answer yet, the first step is getting one. The FM1® Test is a DNA-based blood test that looks for immune system changes related to fibromyalgia, chronic pain and fatigue. Our test is also linked to a no-cost clinical trial for people who test positive.

Fm1test
Get Clearer Evidence for Fibromyalgia
The FM1® Test uses a blood sample to identify DNA signatures related to fibromyalgia, chronic pain and fatigue.
Visit

TL;DR

  • Clinical trials test treatments in volunteers. They are research, not a diagnostic service, and they do not guarantee that a treatment will work.
  • Eligibility is set trial by trial and usually depends on your diagnosis, age, health conditions and past treatments, so a confirmed diagnosis moves you forward faster.
  • Search ClinicalTrials.gov and the NIH HEAL list, then contact the study team for pre-screening before you sign anything.
  • Before enrolling, ask about costs, injury coverage, compensation, privacy and your right to leave at any time.
  • The FM1 Test needs a quick blood draw, is Medicare- and insurance-covered, returns results within about a week, and leads to a no-cost clinical trial for positive respondents.

Table of Contents

What a chronic pain clinical trial actually is

A clinical trial investigates a specific treatment or protocol for a health condition or symptom. Volunteers who have the condition receive the treatment and report side effects and outcomes. That information is part of the process of approving a new treatment so it can be made available to everyone, as the U.S. Pain Foundation explains.

This is different from a diagnostic test. A test asks what is going on in your body. A trial asks whether a treatment helps people who already have a given condition. That is why the two work well in sequence: the test gives you evidence about your condition, and the trial gives you a route to a possible treatment.

The stages you will see in listings

Listings often mention phases, and the label tells you what to expect.

Chronic pain trials also run longer than acute pain studies. The proof-of-concept review notes treatment periods of weeks to months, run in outpatient pain clinics, compared with hours to days in a hospital after surgery.

What researchers are studying right now

The research is broad, and it helps to know what a listing means when you read one.

A systematic review of phase 1 to 3 trials for fibromyalgia, complex regional pain syndrome and chronic low back pain, covering January 2014 to July 2024, found that most trials repurposed antidepressants, antiepileptics, psychedelics and immune modulators. The most promising candidates targeted cannabinoid, glutamate, GABAergic, neuroinflammatory and immune mechanisms.

For fibromyalgia specifically, a July 2026 review lists pregabalin, duloxetine and milnacipran as the FDA-approved drugs. It names central sensitization, NLRP3 inflammasome inhibition, oxidative stress and mitochondrial dysfunction among the research frontiers. Central sensitization means the nervous system amplifies pain signals.

Not every trial tests a drug. The University of Michigan Chronic Pain and Fatigue Research Center studies how the central nervous system contributes to pain and fatigue. It uses neuroimaging, sensory testing, genetics and patient-reported outcomes, and it evaluates non-drug approaches such as cognitive-behavioral therapy, exercise and acupuncture alongside drugs.

Some studies are built to look like everyday care. The 2023 IMMPACT statement on pragmatic pain trials says they can include patients with several health conditions, which stricter designs often exclude. If you have more than one condition, those studies may be worth looking for.

Researchers working on cannabis-based options have also written about the cannabis derivatives and the opioid crisis, one of the areas that clinical trials are testing.

How outcomes are measured

Pain is subjective, so trials depend on scales that patients fill out. The 2020 confirmatory-trials review points out that the accuracy of a pain measurement depends on both the scale and the person using it. Expect daily diaries, questionnaires and regular visits. Studies also track side effects, because safety is always measured. If you want to understand how different approaches to long-term pain relief are judged, the same idea applies: clear outcome measures decide whether a result counts.

Where to find a trial and check that it is open

Start with these places:

  1. ClinicalTrials.gov. The public registry of studies. Each entry shows the conditions studied, eligibility, locations and recruiting status.
  2. NIH HEAL. The HEAL-funded pain studies list shows US states and links each title to its ClinicalTrials.gov entry. It includes a fibromyalgia TENS physical therapy study and a home electrical acustimulation trial.
  3. University research pages. Academic medical centers post their own pain studies, such as UCSD’s pain trials page, which lists cannabis-related studies with age ranges and the length of each study period.
  4. Advocacy groups and your care team. The U.S. Pain Foundation lists patient advocacy groups, registries, health care providers and local pain management centers as ways to find studies.

Recruiting status and locations change often, so always read the current entry rather than a copied summary. Once you find a study, contact the study team, usually the principal investigator or a research coordinator, for pre-screening.

If you are specifically looking at fibromyalgia, our guide to fibromyalgia clinical trials walks through how to find, qualify for and join one.

Who qualifies and how screening works

Eligibility differs by trial. The Clinical Trials Education resource says criteria may relate to safety, age, diagnosis, health conditions and previous treatments.

Two real examples show how specific this gets:

  • A Danish back pain trial protocol, MOCHA, required ages 18 to 64, pain for at least three months on most days, activity limitation, and an average pain intensity of at least 4 out of 10 over the past week. Opioid use and known alcohol or substance abuse were exclusions.
  • The FORWARD Fibromyalgia study states that participants must be at least 18, have fibromyalgia or its symptoms and have no other pain-causing conditions. Its screening period lasts up to four weeks, and participants keep a daily electronic pain diary.

You can see the pattern. Trials need a defined condition, and many want to rule out other causes of pain. That is where an objective result helps you.

The usual path

  1. Pre-screening. The study team asks a few questions to see whether you might fit.
  2. Informed consent. You receive a document covering what is studied, the visits, tests, time commitment, risks and benefits. You sign it before screening begins.
  3. Screening. It may include health questions, a medical record review, a physical exam, and blood or urine tests.
  4. Enrollment. If you meet the criteria, you choose whether to join.
  5. Baseline. You usually complete lab work, scans or questionnaires so researchers know your starting point.

The U.S. Pain Foundation guide adds that many studies exclude people who are pregnant or breastfeeding, and some require contraception. Studies generally identify participants by a unique study ID rather than by name.

Why a confirmed diagnosis matters before you apply

If you live with widespread pain and exhaustion, you may have heard that nothing shows up on routine tests. Trial teams, though, need to know what condition they are enrolling. A diagnosis that rests on a recorded, objective result gives you a stronger starting point when you speak with a study team.

The FM1 Test is built for that moment. It is a blood test that uses DNA science to identify immune system changes related to fibromyalgia, chronic pain and fatigue. According to our own materials, it identifies specific DNA genomic signatures in positive patients. It requires a quick blood draw at a local facility, and results come within about a week. It is Medicare- and insurance-covered.

If you want to understand the usual diagnostic route first, read how doctors diagnose fibromyalgia. To work out whether your symptoms point to fibromyalgia or to another pain condition, see chronic pain vs. fibromyalgia. Our page on Medicare and fibromyalgia testing coverage explains what coverage means for the test.

What to expect once you are in

In most trials, participants are randomly assigned to the experimental treatment, standard of care or a placebo. A placebo is an inactive treatment used for comparison. The U.S. Pain Foundation guide notes that some trials require you to stop usual pain medications, and that many pain trials provide a rescue medication if relief is inadequate.

Staff explain how to use the experimental treatment, how to track symptoms and side effects, and which visits are in person or virtual. A study can run for months. The FORWARD study, for example, describes participation of up to 30 weeks with up to 12 in-person visits and 2 remote ones.

Keep a realistic outlook. As an industry physician quoted by the U.S. Pain Foundation puts it, research carries no guarantee that a drug will work or be safe. The same expert advises reviewing the informed consent with your health care provider to check interactions with your current or future medications. That conversation is where you should raise any question about your own medicines. Our guide to talking to your doctor about chronic pain helps you prepare for it.

What to expect once you are in

Questions to ask about costs, rights and privacy

The federal Office for Human Research Protections suggests asking:

  • Does taking part cost anything, and what will my insurance cover?
  • Who pays for medical care if I am harmed?
  • Are travel or child-care costs reimbursed?
  • How much compensation is offered, and when is it paid?

Two more sources give useful detail. Emory University’s participant FAQ says participation usually costs nothing, because studies are funded by government, industry or philanthropy. It says some studies reimburse time and expenses, and that you may withdraw at any time without penalty and ask that your data or specimens not be used. The MRCT Center guide notes that sponsors often pay for the medicine studied, while coverage of other costs varies. It also advises keeping receipts and asking who pays if you are injured.

The consent form itself must cover the research purpose, timeline, procedures, foreseeable risks, potential benefits, alternatives, privacy protections, contact information and a statement that participation is voluntary, according to the NCATS consent toolkit. Read it fully, and take it home before you sign.

Your next step with the FM1 Test

If your goal is to join a study, begin with the evidence a study team can work with. The FM1 Test is a quick blood draw, covered by Medicare and insurance, with results in about a week. Positive respondents are offered a no-cost clinical trial. You can read more on our research page and in the FM1 Test FAQ.

Fm1test

Ready to find out? Start your FM1 Test. If you want to learn what comes after a result, read what to expect after your fibromyalgia diagnosis.

Our perspective

For many of the people who reach us, the hardest part was never the pain. It was being told the pain could not be proven. Trials are the way new treatments get built, but they are designed around defined conditions, and people without an objective answer are often left at the edge of that process.

That is why we built the FM1 Test around DNA science. It looks for immune system changes related to fibromyalgia, chronic pain and fatigue, and it identifies specific genomic signatures in positive patients. We believe this gives people scientifically backed evidence that fibromyalgia is a legitimate medical condition, not simply a collection of symptoms.

We also believe that a result should lead somewhere. That is why positive respondents are offered a no-cost clinical trial. Evidence first, then a path forward: that is the order we think patients deserve.

the author

FAQ

Do I need a diagnosis to join a chronic pain trial?

Most trials define the condition they study, so some form of diagnosis is usually part of the criteria. Eligibility may also depend on age, other health conditions and previous treatments. A confirmed, objective result such as the FM1 Test gives you a clear answer to bring to a study team.

Will I get a placebo?

It is possible. In most trials, participants are randomly assigned to the experimental treatment, standard of care or a placebo. Many pain trials provide rescue medication if relief is inadequate. Ask the study team exactly how assignment and rescue medication work before you sign.

Does it cost money to take part?

Participation usually costs nothing, since government, industry or philanthropy funds the studies, according to Emory’s participant FAQ. Coverage of other costs, such as routine care or travel, varies by study, so ask. Positive FM1 Test respondents are offered a no-cost clinical trial.

Can I leave a trial once I start?

Yes. Participation is voluntary, and you can stop at any time without penalty. You may also ask that your data or specimens not be used. The consent form describes what early withdrawal could mean, such as tapering off a study drug.

Sources

Apply Now